INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 368 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2024. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,798,536 | -42.1% | 40,861 | -41.5% | 0.00% | 0.0% |
| Q1 2024 | $4,833,101 | +13.9% | 69,843 | +17.9% | 0.00% | 0.0% |
| Q4 2023 | $4,243,807 | +52.2% | 59,255 | +10.7% | 0.00% | 0.0% |
| Q3 2023 | $2,788,300 | -35.8% | 53,529 | -22.0% | 0.00% | 0.0% |
| Q2 2023 | $4,344,291 | +68.4% | 68,609 | +44.1% | 0.00% | 0.0% |
| Q1 2023 | $2,579,057 | +62.3% | 47,628 | +58.6% | 0.00% | – |
| Q4 2022 | $1,589,346 | +5.3% | 30,033 | -7.4% | 0.00% | – |
| Q3 2022 | $1,510,000 | -19.9% | 32,447 | -1.8% | 0.00% | -100.0% |
| Q2 2022 | $1,885,000 | -29.1% | 33,034 | -24.0% | 0.00% | 0.0% |
| Q1 2022 | $2,659,000 | -34.4% | 43,454 | -43.9% | 0.00% | 0.0% |
| Q4 2021 | $4,052,000 | +83.2% | 77,408 | +30.5% | 0.00% | – |
| Q3 2021 | $2,212,000 | -1.2% | 59,328 | +8.1% | 0.00% | – |
| Q2 2021 | $2,240,000 | +7.3% | 54,862 | -10.8% | 0.00% | – |
| Q1 2021 | $2,087,000 | -41.1% | 61,493 | -44.8% | 0.00% | -100.0% |
| Q4 2020 | $3,541,000 | +63.5% | 111,347 | +32.0% | 0.00% | 0.0% |
| Q3 2020 | $2,166,000 | +49.5% | 84,384 | -44.9% | 0.00% | – |
| Q2 2020 | $1,449,000 | +212.3% | 153,196 | +407.9% | 0.00% | – |
| Q1 2020 | $464,000 | -44.8% | 30,165 | +23.0% | 0.00% | – |
| Q4 2019 | $841,000 | +380.6% | 24,533 | +4.3% | 0.00% | – |
| Q3 2019 | $175,000 | -34.9% | 23,531 | +13.4% | 0.00% | – |
| Q2 2019 | $269,000 | -12.4% | 20,742 | -17.7% | 0.00% | – |
| Q1 2019 | $307,000 | -41.6% | 25,215 | -63.0% | 0.00% | – |
| Q4 2018 | $526,000 | -5.7% | 68,120 | +164.9% | 0.00% | – |
| Q3 2018 | $558,000 | +31.0% | 25,719 | +6.6% | 0.00% | – |
| Q2 2018 | $426,000 | -20.2% | 24,130 | -4.8% | 0.00% | – |
| Q1 2018 | $534,000 | +65.3% | 25,352 | +13.8% | 0.00% | – |
| Q4 2017 | $323,000 | -41.1% | 22,287 | -35.9% | 0.00% | – |
| Q3 2017 | $548,000 | +34.0% | 34,756 | +5.7% | 0.00% | – |
| Q2 2017 | $409,000 | -71.5% | 32,876 | -62.7% | 0.00% | – |
| Q1 2017 | $1,433,000 | +0.1% | 88,195 | -7.1% | 0.00% | -100.0% |
| Q4 2016 | $1,431,000 | +538.8% | 94,889 | +545.5% | 0.00% | – |
| Q3 2016 | $224,000 | -50.4% | 14,700 | +26.3% | 0.00% | – |
| Q2 2016 | $452,000 | +55.9% | 11,641 | +11.5% | 0.00% | – |
| Q1 2016 | $290,000 | -50.6% | 10,438 | -4.4% | 0.00% | – |
| Q4 2015 | $587,000 | +190.6% | 10,916 | +116.9% | 0.00% | – |
| Q3 2015 | $202,000 | +5.2% | 5,033 | -16.4% | 0.00% | – |
| Q2 2015 | $192,000 | -6.8% | 6,021 | -30.7% | 0.00% | – |
| Q1 2015 | $206,000 | +1371.4% | 8,686 | +995.3% | 0.00% | – |
| Q4 2014 | $14,000 | +27.3% | 793 | +0.8% | 0.00% | – |
| Q3 2014 | $11,000 | -47.6% | 787 | -35.3% | 0.00% | – |
| Q2 2014 | $21,000 | – | 1,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
| Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
| Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
| WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
| SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
| Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
| EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
| Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |